Drug Type Small molecule drug |
Synonyms MK 0617, MK0617 |
Target |
Action antagonists |
Mechanism α4β1 antagonists(Integrin alpha-4/beta-1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Preclinical | United States | 01 Oct 2009 | |
Multiple Sclerosis | Preclinical | United States | 01 Oct 2009 | |
Rheumatoid Arthritis | Preclinical | United States | 01 Oct 2009 |